Joel B. Braunstein

Joel B. Braunstein is the Co-Founder, President, and CEO of C2N Diagnostics. Joel has over 20 years of experience in the healthcare industry, including founding Tivorsan Pharmaceuticals and serving as a Board Member for NexGen Medical Systems, Inc. and LifeTech Research, Inc.

Joel B. Braunstein earned their MD from Johns Hopkins University School of Medicine in 1996 and completed their residency in internal medicine at Brigham and Women's Hospital in 1999. Joel then went on to complete a fellowship in cardiovascular medicine at Johns Hopkins Medicine from 1999 to 2001. In 2001, they were named a Clinical Scholar by the Robert Wood Johnson Foundation. In 2010, they co-founded Tivorsan Pharmaceuticals and served as its CEO until 2019. In 2018, they co-founded C2N Diagnostics and currently serves as its President and CEO.

Joel B. Braunstein is a medical doctor who attended Northwestern University - The Feinberg School of Medicine. Joel also has an MBA from The Johns Hopkins University - Carey Business School.

Some individuals on their team include Kevin Yarasheski - Senior Vice President, Joni Henderson - Director, Marketing, Outreach & Strategic Growth, and Micah Onixt - General Counsel, Privacy Officer & Corporate Secretary.